OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Outset Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.80−0.14 (-3.55%)
Close on Oct 19, 2026
- Market cap
- $70.75K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
75.5%
14M of 19M shares
Institutional holders
93
20 new, 22 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 23 sales
Net sold $369.19K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| AQR Capital Management, LLC | 998,961 | 5.39% | 13G (passive) | Jun 30, 2026 |
| Perceptive Advisors LLC | 5,625,000 | 9.50% | 13G (passive) | Jan 8, 2025 |
| BML Investment Partners, L.P. | 2,764,610 | 14.70% | 13G (passive) amendment | Oct 2, 2026 |
| Abigail P. Johnson | 2,596,861 | 14.50% | 13G (passive) amendment | Mar 31, 2025 |
| Alyeska Investment Group, L.P. | 1,703,083 | 9.61% | 13G (passive) | Mar 31, 2025 |
| Perceptive Credit Advisors, LLC | 1,208,334 | 6.70% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of OM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 2,742,887 | 14.59% | $11.85M | +1,214 | 0.00% |
| BML Capital Management, LLC | 2,519,701 | 13.40% | $10.89M | +617,500 | 6.18% |
| Aqr Capital Management LLC | 998,961 | 5.31% | $4.32M | +190,676 | 0.00% |
| Perceptive Advisors LLC | 833,333 | 4.43% | $3.60M | – | 0.05% |
| Vanguard Capital Management LLC | 780,134 | 4.15% | $3.37M | +16,312 | 0.00% |
| Assenagon Asset Management S.A. | 678,876 | 3.61% | $2.93M | +174,783 | 0.00% |
| Bank Of America Corp /De/ | 665,847 | 3.54% | $2.88M | −283,550 | 0.00% |
| PFM Health Sciences, LP | 582,122 | 3.10% | $2.51M | −12,508 | 0.22% |
| Ensign Peak Advisors, Inc | 434,341 | 2.31% | $1.88M | −92,244 | 0.00% |
| BlackRock, Inc. | 418,211 | 2.22% | $1.81M | −845,008 | 0.00% |
| Peapod Lane Capital LLC | 331,951 | 1.77% | $1.43M | New | 0.97% |
| Marshall Wace, Llp | 211,993 | 1.13% | $915.81K | New | 0.00% |
| Geode Capital Management, LLC | 204,652 | 1.09% | $884.54K | −216,721 | 0.00% |
| Stratos Wealth Partners, LTD. | 200,546 | 1.07% | $866.36K | – | 0.01% |
| UBS Group AG | 190,289 | 1.01% | $822.05K | −62,210 | 0.00% |
| Morgan Stanley | 181,983 | 0.97% | $786.17K | +12,540 | 0.00% |
| Millennium Management LLC | 181,794 | 0.97% | $785.35K | New | 0.00% |
| Goldman Sachs Group Inc | 173,460 | 0.92% | $749.35K | +80,100 | 0.00% |
| Jane Street Group, LLC | 139,197 | 0.74% | $601.33K | +74,387 | 0.00% |
| XTX Topco Ltd | 124,690 | 0.66% | $538.66K | −17,760 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 93 | 14M | 75.5% | 20 / 33 | 26 / 22 | 2M | 3M |
| Q1 2026 | 97 | 15M | 78.6% | 25 / 36 | 21 / 24 | 4M | 4M |
| Q4 2025 | 97 | 15M | 81.8% | 20 / 32 | 26 / 21 | 3M | 5M |
| Q3 2025 | 98 | 18M | 94.5% | 19 / 32 | 33 / 12 | 3M | 4M |
| Q2 2025 | 92 | 19M | 99.4% | 40 / 24 | 14 / 8 | 5M | 1M |
| Q1 2025 | 60 | 15M | 78.1% | 60 / 0 | 0 / 0 | 15M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of OM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Select Health Care Portfolio | 1,520,000 | 8.09% | $7.43M | 0.13% | May 31, 2026 |
| Fidelity Advisor Health Care Fund | 800,000 | 4.26% | $3.66M | 0.12% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 552,827 | 2.94% | $2.39M | 0.00% | Jun 30, 2026 |
| VIP Health Care Portfolio | 280,000 | 1.49% | $1.21M | 0.10% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 206,540 | 1.10% | $892.25K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 98,662 | 0.52% | $482.46K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 85,953 | 0.46% | $420.31K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 57,965 | 0.31% | $250.41K | 0.02% | Jun 30, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 37,640 | 0.20% | $162.60K | 0.00% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 37,179 | 0.20% | $169.91K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 36,109 | 0.19% | $176.57K | 0.00% | May 31, 2026 |
| Fidelity Disruptive Medicine ETF | 34,000 | 0.18% | $166.26K | 0.41% | May 31, 2026 |
| AQR Small Cap Multi-Style Fund | 31,853 | 0.17% | $137.60K | 0.04% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 27,682 | 0.15% | $135.36K | 0.00% | May 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 26,735 | 0.14% | $130.73K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Leslie Trigg | Chair and CEO, Director | 236,847 | 1.26% | Aug 18, 2026 |
| John L. Brottem | General Counsel | 87,475 | 0.47% | Aug 18, 2026 |
| Renee Gaeta | Chief Financial Officer | 180,840 | 0.96% | Aug 18, 2026 |
| Marc Nash | EVP Operations R&D & Service | 38,393 | 0.20% | May 19, 2026 |
| Derick A. Elliott | EVP, Commercial | 96,000 | 0.51% | Apr 8, 2026 |
| Nabeel Ahmed | Chief Financial Officer | 16,096 | 0.09% | May 16, 2025 |
| Karen Drexler | Director | 23,400 | 0.12% | Jun 5, 2026 |
| Karen Prange | Director | 29,334 | 0.16% | Jun 5, 2026 |
| D. Keith Grossman | Director | 37,430 | 0.20% | Jun 5, 2026 |
| Patrick T. Hackett | Director | 230,838 | 1.23% | Jun 5, 2026 |
| Brent D. Lang | Director | 45,184 | 0.24% | Jun 5, 2026 |
| Kevin C. Oboyle | Director | 34,785 | 0.19% | Jun 5, 2026 |
| Andrea Lynn Saia | Director | 12,175 | 0.06% | Jun 4, 2025 |
| Braden Michael Leonard | 10% owner | 2,519,701 | 13.40% | May 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John L. Brottem General Counsel | Aug 17, 2026 | Sale | −2,632 | $4.39 | $11.55K | 87,475 |
| Renee Gaeta Chief Financial Officer | Aug 17, 2026 | Sale | −4,543 | $4.39 | $19.94K | 180,840 |
| Leslie Trigg Chair and CEO, Director | Aug 17, 2026 | Sale | −3,437 | $4.39 | $15.09K | 194,597 |
| John L. Brottem General Counsel | Jun 26, 2026 | Award | +59,830 | – | – | 90,107 |
| Renee Gaeta Chief Financial Officer | Jun 26, 2026 | Award | +71,630 | – | – | 185,383 |
| Leslie Trigg Chair and CEO, Director | Jun 26, 2026 | Award | +99,160 | – | – | 198,034 |
| D. Keith Grossman Director | Jun 4, 2026 | Award | +10,667 | – | – | 24,585 |
| Karen Prange Director | Jun 4, 2026 | Award | +10,667 | – | – | 29,334 |
| Karen Drexler Director | Jun 4, 2026 | Award | +10,667 | – | – | 21,317 |
| Kevin C. Oboyle Director | Jun 4, 2026 | Award | +10,667 | – | – | 34,785 |
| Patrick T. Hackett Director | Jun 4, 2026 | Award | +10,667 | – | – | 105,839 |
| Brent D. Lang Director | Jun 4, 2026 | Award | +10,667 | – | – | 28,518 |
| Renee Gaeta Chief Financial Officer | Jun 3, 2026 | Sale | −17,672 | $4.94 | $87.30K | 113,753 |
| Leslie Trigg Chair and CEO, Director | May 15, 2026 | Sale | −3,445 | $3.70 | $12.75K | 98,874 |
| Marc Nash EVP Operations R&D & Service | May 15, 2026 | Sale | −1,582 | $3.70 | $5.85K | 38,393 |
| John L. Brottem General Counsel | May 15, 2026 | Sale | −2,638 | $3.70 | $9.76K | 30,277 |
| Braden Michael Leonard 10% owner | May 15, 2026 | Option exercise | +323,000 | $5.00 | $1.62M | 2,519,701 |
| Braden Michael Leonard 10% owner | May 11, 2026 | Option exercise | +96,900 | $5.00 | $484.50K | 2,196,701 |
| Braden Michael Leonard 10% owner | May 8, 2026 | Option exercise | +197,600 | $5.00 | $988.00K | 2,099,801 |
| Derick A. Elliott EVP, Commercial | Apr 6, 2026 | Award | +96,000 | – | – | 96,000 |
| John L. Brottem General Counsel | Feb 17, 2026 | Sale | −2,842 | $3.35 | $9.52K | 32,935 |
| Marc Nash EVP Operations R&D & Service | Feb 17, 2026 | Sale | −1,817 | $3.35 | $6.09K | 39,988 |
| Leslie Trigg Chair and CEO, Director | Feb 17, 2026 | Sale | −3,361 | $3.35 | $11.26K | 102,342 |
| Marc Nash EVP Operations R&D & Service | Jan 21, 2026 | Sale | −980 | $4.98 | $4.88K | 41,805 |
| Leslie Trigg Chair and CEO, Director | Jan 21, 2026 | Sale | −2,120 | $5.05 | $10.71K | 105,703 |
| John L. Brottem General Counsel | Jan 21, 2026 | Sale | −1,180 | $5.01 | $5.91K | 35,777 |
| Marc Nash EVP Operations R&D & Service | Jan 20, 2026 | Sale | −5,375 | $5.12 | $27.52K | 42,785 |
| Leslie Trigg Chair and CEO, Director | Jan 20, 2026 | Sale | −11,794 | $5.12 | $60.39K | 107,823 |
| John L. Brottem General Counsel | Jan 20, 2026 | Sale | −9,314 | $5.12 | $47.69K | 36,957 |
| Karen Prange Director | Jan 9, 2026 | Award | +18,667 | – | – | 18,667 |
| John L. Brottem General Counsel | Jan 7, 2026 | Sale | −224 | $4.27 | $956 | 46,271 |
| Leslie Trigg Chair and CEO, Director | Jan 7, 2026 | Sale | −1,795 | $4.27 | $7.66K | 119,617 |
| Marc Nash EVP Operations R&D & Service | Jan 7, 2026 | Sale | −108 | $4.27 | $461 | 48,160 |
| Karen Drexler Director | Dec 1, 2025 | Sale | −1,548 | $4.37 | $6.76K | 10,650 |
| Marc Nash EVP Operations R&D & Service | Nov 17, 2025 | Sale | −247 | $4.60 | $1.14K | 48,268 |
| John L. Brottem General Counsel | Nov 17, 2025 | Sale | −388 | $4.60 | $1.78K | 46,495 |
| Leslie Trigg Chair and CEO, Director | Nov 17, 2025 | Sale | −916 | $4.60 | $4.21K | 121,412 |
| Marc Nash EVP, R&D, Operations and Serv. | Aug 25, 2025 | Award | +5,617 | – | – | 48,515 |
| John L. Brottem General Counsel | Aug 15, 2025 | Sale | −383 | $12.88 | $4.93K | 46,883 |
| Leslie Trigg Chair and CEO, Director | Aug 15, 2025 | Sale | −904 | $12.88 | $11.64K | 122,328 |
| Marc Nash SVP Operations and R&D | Aug 15, 2025 | Sale | −243 | $12.88 | $3.13K | 42,898 |
| Renee Gaeta Chief Financial Officer | Jun 10, 2025 | Award | +131,425 | – | – | 131,425 |
| John L. Brottem General Counsel | Jun 10, 2025 | Award | +35,993 | – | – | 47,266 |
| Leslie Trigg Chair and CEO, Director | Jun 10, 2025 | Award | +65,103 | – | – | 123,232 |
| Marc Nash SVP Operations and R&D | Jun 10, 2025 | Award | +29,676 | – | – | 43,141 |
| D. Keith Grossman Director | Jun 2, 2025 | Award | +8,983 | – | – | 13,918 |
| Karen Drexler Director | Jun 2, 2025 | Award | +8,983 | – | – | 12,198 |
| Kevin C. Oboyle Director | Jun 2, 2025 | Award | +8,983 | – | – | 24,118 |
| Brent D. Lang Director | Jun 2, 2025 | Award | +8,983 | – | – | 17,851 |
| Patrick T. Hackett Director | Jun 2, 2025 | Award | +8,983 | – | – | 95,172 |
| Andrea Lynn Saia Director | Jun 2, 2025 | Award | +8,983 | – | – | 12,175 |
| Leslie Trigg Chair and CEO, Director | May 15, 2025 | Sale | −935 | $17.80 | $16.64K | 58,129 |
| Nabeel Ahmed Chief Financial Officer | May 15, 2025 | Sale | −584 | $17.81 | $10.40K | 16,096 |
| Marc Nash SVP Operations and R&D | May 15, 2025 | Sale | −252 | $17.82 | $4.49K | 13,465 |
| John L. Brottem General Counsel | May 15, 2025 | Sale | −396 | $17.82 | $7.06K | 11,273 |
| Kevin C. Oboyle Director | May 14, 2025 | Award | +15,135 | – | – | 15,135 |
| Karen Drexler Director | Mar 10, 2025 | Option exercise | +31,250 | – | – | 31,250 |
| Patrick T. Hackett Director | Mar 10, 2025 | Option exercise | +1,250,000 | – | – | 1,292,849 |
| Patrick T. Hackett Director | Mar 10, 2025 | Option exercise | +1,250,000 | – | – | 1,250,000 |
| Patrick T. Hackett Director | Mar 10, 2025 | Option exercise | +625,000 | – | – | 625,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Renee Gaeta Officer | Aug 14, 2026 | 4,422 | $19.94K | Aug 17, 2026 | Settlement of Vested Restricted Stock Units |
| John L. Brottem Officer | Aug 14, 2026 | 2,562 | $11.55K | Aug 17, 2026 | Settlement of Vested Restricted Stock Units |
| Leslie Trigg Officer | Aug 14, 2026 | 3,344 | $15.08K | Aug 17, 2026 | Settlement of Vested Restricted Stock Units |
| Renee Gaeta Officer | Jun 3, 2026 | 17,672 | $87.38K | Jun 3, 2026 | Settlement of Vested Restricted Stock Units |
| Leslie Trigg Officer | May 15, 2026 | 3,445 | $12.75K | May 15, 2026 | Settlement of Vested Restricted Stock Units |
| Marc Nash Officer | May 15, 2026 | 1,582 | $5.85K | May 15, 2026 | Settlement of Vested Restricted Stock Units |
| John L. Brottem Officer | May 15, 2026 | 2,638 | $9.76K | May 15, 2026 | Settlement of Vested Restricted Stock Units |
| John L. Brottem Officer | Feb 17, 2026 | 2,842 | $9.52K | Feb 17, 2026 | Settlement of Vested Restricted Stock Units |
| Leslie Trigg Officer | Feb 17, 2026 | 3,361 | $11.26K | Feb 17, 2026 | Settlement of Vested Restricted Stock Units |
| Marc Nash Officer | Jan 21, 2026 | 980 | $4.88K | Jan 21, 2026 | Settlement of Vested Restricted Stock Units |
| Leslie Trigg Officer | Jan 21, 2026 | 2,120 | $10.70K | Jan 21, 2026 | Settlement of Vested Restricted Stock Units |
| John L. Brottem Officer | Jan 21, 2026 | 1,180 | $5.91K | Jan 21, 2026 | Settlement of Vested Restricted Stock Units |
| John L. Brottem Officer | Jan 20, 2026 | 9,314 | $47.68K | Jan 20, 2026 | Settlement of Vested Restricted Stock Units |
| Leslie Trigg Officer | Jan 20, 2026 | 11,794 | $60.39K | Jan 20, 2026 | Settlement of Vested Restricted Stock Units |
| Marc Nash Officer | Jan 20, 2026 | 5,375 | $27.52K | Jan 20, 2026 | Settlement of Vested Restricted Stock Units |